Survival analysis in Kaplan-Meier Plotte (16) revealed that the OS of HCC patients with high expression of BAK1 was significantly lower than that of patients with low expression of BAK1 (P = 0.001) in TCGA cohort (Figure 9E) while there was no significant difference in RFS (P = 0.13) (Figure 9F). Here, BAK1 is linked to hepatocellular carcinoma.